VALANX Biotech
PrivateLast Round
Series A
Mar 12, 2026
Total Funding Raised
$3.55M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
VALANX Biotech is a biotechnology company that has developed a proprietary platform for site-specific protein conjugation to create antibody-drug conjugates (ADCs) and other biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VALANX Biotech Comparables
Compare VALANX Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrickBio, Inc. | 87% | |
| Catena Biosciences | 84% | |
| Onegene Biotechnology | 79% |
VALANX Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 12, 2026 | ||||
| VC Round | Nov 7, 2023 | ||||
| Seed | May 1, 2020 | ||||
| Accelerator | Jun 16, 2017 |
VALANX Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| tecnet equity | Seed, Series A, VC Round |
| Skygene | Series A, VC Round |
| xista science ventures | Seed, VC Round |
| xista science ventures | Series A |
| RebelBio | Accelerator |
| SOSV | Seed, Series A, VC Round, Accelerator |
| Fondation Fournier-Majoie | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
Grew 21% QoQ, from 14 to 17 employees.
- Apr 15, 2026
Monthly visitors increased 144% MoM, reaching 268.
VALANX Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VALANX Biotech's valuation, stock price, and market status.
Is VALANX Biotech a public or private company?
VALANX Biotech is a private company.
What is the current stock price of VALANX Biotech?
VALANX Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is VALANX Biotech worth (valuation)?
Valuation information for VALANX Biotech is not publicly available.
Can I buy VALANX Biotech stock?
VALANX Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VALANX Biotech's last funding round?
VALANX Biotech's most recent funding round was Series A on March 12, 2026.
Who are the main investors in VALANX Biotech?
Key investors in VALANX Biotech include Skygene, RebelBio, Fondation Fournier-Majoie, Fujifilm Corporation.
Will VALANX Biotech IPO soon?
No public IPO plans have been announced for VALANX Biotech.
How can I track VALANX Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VALANX Biotech's secondary market activity and sign up for updates.